HIV Citation List: June 8 - June 21, 2012

PubMed citations

1. Synthesis and Biological Evaluation of Tricyclic Guanidine Analogues of Batzelladine K for Antimalarial, Antileishmanial, Antibacterial, Antifungal and anti-HIV Activities. Ahmed, N., K.G. Brahmbhatt, S.I. Khan, M. Jacob, B.L. Tekwani, S. Sabde, D. Mitra, I.P. Singh, I.A. Khan, and K.K. Bhutani, Chemical Biology and Drug Design, 2012. [Epub ahead of print]; PMID[22703590].

[PubMed]. HIV_0608-062112.

2. Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-transcriptase Inhibitors. Brehm, J.H., D.L. Koontz, C.L. Wallis, K.A. Shutt, I. Sanne, R. Wood, J.A. McIntyre, W.S. Stevens, N. Sluis-Cremer, and J.W. Mellors, Clinical Infectious Disease, 2012. [Epub ahead of print]; PMID[22618567].

[PubMed]. HIV_0608-062112.

3. Design, Synthesis, anti-HIV Evaluation and Molecular Modeling of Piperidine-linked Amino-triazine Derivatives as Potent Non-nucleoside Reverse Transcriptase Inhibitors. Chen, X., P. Zhan, X. Liu, Z. Cheng, C. Meng, S. Shao, C. Pannecouque, and E.D. Clercq, Bioorganic & Medicinal Chemistry, 2012. 20(12): p. 3856-3864; PMID[22591854].

[PubMed]. HIV_0608-062112.

4. Discovery of Critical Residues for Viral Entry and Inhibition through Structural Insight of HIV-1 Fusion Inhibitor CP621-652. Chong, H., X. Yao, Z. Qiu, B. Qin, R. Han, S. Waltersperger, M. Wang, S. Cui, and Y. He, Journal of Biological Chemistry, 2012. 287(24): p. 20281-20289; PMID[22511760].

[PubMed]. HIV_0608-062112.

5. A Peptide Nucleic Acid-aminosugar Conjugate Targeting Transactivation Response Element of HIV-1 RNA Genome Shows a High Bioavailability in Human Cells and Strongly Inhibits Tat-mediated Transactivation of HIV-1 Transcription. Das, I., J. Desire, D.K. Manvar, I. Baussanne, V.N. Pandey, and J.L. Decout, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22698070].

[PubMed]. HIV_0608-062112.

6. Bifunctional CD4-DC-SIGN Fusion Proteins Demonstrate Enhanced Avidity to gp120 and Inhibit HIV-1 Infection and Dissemination. Du, T., K. Hu, J. Yang, J. Jin, C. Li, D. Stieh, G.E. Griffin, R.J. Shattock, and Q. Hu, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22687513].

[PubMed]. HIV_0608-062112.

7. Miltefosine Represses HIV-1 Replication in Human Dendritic Cell/T-cell Cocultures Partially by Inducing Secretion of Type-I Interferon.. Garg, R. and M.J. Tremblay, Virology, 2012. [Epub ahead of print]; PMID[22704066].

[PubMed]. HIV_0608-062112.

8. Ethnopharmacology in Overdrive: The Remarkable anti-HIV Activity of Artemisia annua. Lubbe, A., I. Seibert, T. Klimkait, and F. van der Kooy, Journal of Ethnopharmacology, 2012. 141(3): p. 854-859; PMID[22465592].

[PubMed]. HIV_0608-062112.

9. Response of SIV to the Novel Nucleoside Reverse Transcriptase Inhibitor 4' -Ethynyl-2-fluoro-2' -deoxyadenosine (EFdA) in Vitro and in Vivo. Murphey-Corb, M., P. Rajakumar, H. Michael, J. Nyaundi, P.J. Didier, A.B. Reeve, H. Mitsuya, S.G. Sarafianos, and M.A. Parniak, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22713337].

[PubMed]. HIV_0608-062112.

10. Pharmacophore-based Small Molecule CXCR4 Ligands. Narumi, T., T. Tanaka, C. Hashimoto, W. Nomura, H. Aikawa, A. Sohma, K. Itotani, M. Kawamata, T. Murakami, N. Yamamoto, and H. Tamamura, Bioorganic & Medicinal Chemistry Letters, 2012. 22(12): p. 4169-4172; PMID[22579418].

[PubMed]. HIV_0608-062112.

11. Design, Synthesis, Biological and Structural Evaluations of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance. Parai, M.K., D.J. Huggins, H. Cao, M.N. Nalam, A. Ali, C.A. Schiffer, B. Tidor, and T.M. Rana, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22708897].

[PubMed]. HIV_0608-062112.

12. Antiretroviral Agents Effectively Block HIV Replication after Cell to Cell Transfer. Permanyer, M., E. Ballana, A. Ruiz, R. Badia, E. Riveira-Munoz, E. Gonzalo, B. Clotet, and J.A. Este, Journal of Virology, 2012. [Epub ahead of print]; PMID[22696642].

[PubMed]. HIV_0608-062112.

13. Inhibition of HIV-1 Tat-induced Transactivation and Apoptosis by the Divalent Metal Chelators, Fusaric Acid and Picolinic Acid-implications for HIV-1 Dementia. Ramautar, A., M. Mabandla, J. Blackburn, and W.M. Daniels, Neuroscience Research, 2012. [Epub ahead of print]; PMID[22698778].

[PubMed]. HIV_0608-062112.

14. Development of a Series of 3-Hydroxyquinolin-2(1H)-ones as Selective Inhibitors of HIV-1 Reverse Transcriptase Associated RNase H Activity. Suchaud, V., F. Bailly, C. Lion, E. Tramontano, F. Esposito, A. Corona, F. Christ, Z. Debyser, and P. Cotelle, Bioorganic & Medicinal Chemistry Letters, 2012. 22(12): p. 3988-3992; PMID[22607675].

[PubMed]. HIV_0608-062112.

15. New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action. Tsiang, M., G.S. Jones, A. Niedziela-Majka, E. Kan, E.B. Lansdon, W. Huang, M. Hung, D. Samuel, N. Novikov, Y. Xu, M. Mitchell, H. Guo, K. Babaoglu, X. Liu, R. Geleziunas, and R. Sakowicz, Journal of Biological Chemistry, 2012. 287(25): p. 21189-21203; PMID[22535962].

[PubMed]. HIV_0608-062112.

16. Dual Inhibitors for Aspartic Proteases HIV-1 PR and Renin: Advancements in AIDS-hypertension-diabetes Linkage Via Molecular Dynamics, Inhibition Assays, and Binding Free Energy Calculations. Tzoupis, H., G. Leonis, G. Megariotis, C.T. Supuran, T. Mavromoustakos, and M.G. Papadopoulos, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22621689].

[PubMed]. HIV_0608-062112.

17. Antibody against Integrin LFA-1 Inhibits HIV-1 Infection in Primary Cells through Caspase 8-mediated Apoptosis. Walker, T.N., L.M. Cimakasky, E.M. Coleman, M.N. Madison, and J.E. Hildreth, AIDS Research and Human Retroviruses, 2012. [Epub ahead of print]; PMID[22697794].

[PubMed]. HIV_0608-062112.

18. Efficient Inhibition of HIV-1 Replication by an Artificial Polycistronic miRNA Construct. Zhang, T., T. Cheng, L. Wei, Y. Cai, A.E. Yeo, J. Han, Y.A. Yuan, J. Zhang, and N. Xia, Virology Journal, 2012. 9(1): p. 118; PMID[22709537].

[PubMed]. HIV_0608-062112.

ISI Web of Knowledge Citations

19. Anti-AIDS Agents 88. anti-HIV Conjugates of Betulin and Betulinic Acid with AZT Prepared Via Click Chemistry. Bori, I.D., H.Y. Hung, K.D. Qian, C.H. Chen, S.L. Morris-Natschke, and K.H. Lee, Tetrahedron Letters, 2012. 53(15): p. 1987-1989; ISI[000302451300030].

[WOS]. HIV_0608-062112.

20. Synthesis and Biological Evaluation of Piperidine-substituted Triazine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Chen, X.W., P. Zhan, C. Pannecouque, J. Balzarini, E. De Clercq, and X.Y. Liu, European Journal of Medicinal Chemistry, 2012. 51: p. 60-66; ISI[000304291900006].

[WOS]. HIV_0608-062112.

21. Design, Synthesis, and Antiviral Activity of Entry Inhibitors That Target the CD4-binding Site of HIV-1. Curreli, F., S. Choudhury, I. Pyatkin, V.P. Zagorodnikov, A.K. Bulay, A. Altieri, Y. Do Kwon, P.D. Kwong, and A.K. Debnath, Journal of Medicinal Chemistry, 2012. 55(10): p. 4764-4775; ISI[000304338800018].

[WOS]. HIV_0608-062112.

22. Polymeric Nanoparticles Affect the Intracellular Delivery, Antiretroviral Activity and Cytotoxicity of the Microbicide Drug Candidate Dapivirine. das Neves, J., J. Michiels, K.K. Arien, G. Vanham, M. Amiji, M.F. Bahia, and B. Sarmento, Pharmaceutical Research, 2012. 29(6): p. 1468-1484; ISI[000304117700005].

[WOS]. HIV_0608-062112.

23. The Ledgins: First-in-class Allosteric HIV-1 Integrase Inhibitors. Desimmie, B., Tropical Medicine & International Health, 2012. 17: p. 14-14; ISI[000304244000040].

[WOS]. HIV_0608-062112.

24. Peptides from Second Extracellular Loop of C-C Chemokine Receptor Type 5 (CCR5) Inhibit Diverse Strains of HIV-1. Dogo-Isonagie, C., S. Lam, E. Gustchina, P. Acharya, Y.P. Yang, S. Shahzad-ul-Hussan, G.M. Clore, P.D. Kwong, and C.A. Bewley, Journal of Biological Chemistry, 2012. 287(18): p. 15076-15086; ISI[000304003200069].

[WOS]. HIV_0608-062112.

25. Pharmacologic Inducers of the Macrophage Antioxidant Response Inhibit HIV Infection and Neurotoxin Production. Gill, A., S. Cross, P. Vance, and D. Kolson, Journal of Neurovirology, 2012. 18: p. 41-42; ISI[000304487800087].

[WOS]. HIV_0608-062112.

26. CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant Variant. Kang, Y.X., Z.W. Wu, T.C.K. Lau, X.F. Lu, L. Liu, A.K.L. Cheung, Z.W. Tan, J. Ng, J.G. Liang, H.B. Wang, S.K. Li, B.J. Zheng, B. Li, L. Chen, and Z.W. Chen, Journal of Biological Chemistry, 2012. 287(20): p. 16499-16509; ISI[000304030900040].

[WOS]. HIV_0608-062112.

27. Design and Synthesis of Novel 1 ',3 '-Dioxolane 5 '-deoxyphosphonic Acid Purine Analogues as Potent Antiviral Agents. Kim, E., L.J. Liu, W. Lee, and J.H. Hong, Nucleosides Nucleotides & Nucleic Acids, 2012. 31(1-3): p. 85-96; ISI[000302276700008].

[WOS]. HIV_0608-062112.

28. Vpr as a Regulator of NF-kappa B in HIV-1: Selective Inhibition of the TNF-alpha Pathway. Kogan, M., S. Deshmane, B. Sawaya, K. Khalili, and J. Rappaport, Journal of Neurovirology, 2012. 18: p. 55-56; ISI[000304487800115].

[WOS]. HIV_0608-062112.

29. Structure-based Design, Synthesis, and Characterization of Dual Hotspot Small-molecule HIV-1 Entry Inhibitors. LaLonde, J.M., Y.D. Kwon, D.M. Jones, A.W. Sun, J.R. Courter, T. Soeta, T. Kobayashi, A.M. Princiotto, X.L. Wu, A. Schon, E. Freire, P.D. Kwong, J.R. Mascola, J. Sodroski, N. Madani, and A.B. Smith, Journal of Medicinal Chemistry, 2012. 55(9): p. 4382-4396; ISI[000303785900026].

[WOS]. HIV_0608-062112.

30. Cycloartane Triterpenoids from Cassia occidentalis. Li, S.F., Y.T. Di, R.H. Luo, Y.T. Zheng, Y.H. Wang, X. Fang, Y. Zhang, L. Li, H.P. He, S.L. Li, and X.J. Hao, Planta Medica, 2012. 78(8): p. 821-827; ISI[000304449300013].

[WOS]. HIV_0608-062112.

31. Synthesis, Drug Release and anti-HIV Activity of a Series of Pegylated Zidovudine Conjugates. Li, W.J., J.D. Wu, P. Zhan, Y. Chang, C. Pannecouque, E. De Clercq, and X.Y. Liu, International Journal of Biological Macromolecules, 2012. 50(4): p. 974-980; ISI[000304230000014].

[WOS]. HIV_0608-062112.

32. Therapeutic Potential of HIV Protease-activable CASP3. Miyauchi, K., E. Urano, M. Takizawa, R. Ichikawa, and J. Komano, Scientific Reports, 2012. 2; ISI[000302559000002].

[WOS]. HIV_0608-062112.

33. A Synthetic C34 Trimer of HIV-1 gp41 Shows Significant Increase in Inhibition Potency (Vol 7, Pg 205, 2012). Nomura, W., C. Hashimoto, A. Ohya, K. Miyauchi, E. Urano, T. Tanaka, T. Narumi, T. Nakahara, J.A. Komano, N. Yamamoto, and H. Tamamura, ChemMedChem, 2012. 7(4): p. 546-546; ISI[000302073100001].

[WOS]. HIV_0608-062112.

34. Intramolecular Regulation of the Sequence-specific mRNA Interferase Activity of MazF Fused to a MazE Fragment with a Linker Cleavable by Specific Proteases. Park, J.H., Y. Yamaguchi, and M. Inouye, Applied and Environmental Microbiology, 2012. 78(11): p. 3794-3799; ISI[000304185400002].

[WOS]. HIV_0608-062112.

35. Cleavage of Pyrene-stabilized RNA Bulge Loops by trans-(+/-)-Cyclohexane-1,2-diamine. Patel, S., J. Rana, J. Roy, and H.D. Huang, Chemistry Central Journal, 2012. 6; ISI[000302475000001].

[WOS]. HIV_0608-062112.

36. 2-(Alkyl/Aryl)amino-6-benzylpyrimidin-4(3H)-ones as Inhibitors of Wild-type and Mutant HIV-1: Enantioselectivity Studies. Rotili, D., A. Samuele, D. Tarantino, R. Ragno, I. Musmuca, F. Ballante, G. Botta, L. Morera, M. Pierini, R. Cirilli, M.B. Nawrozkij, E. Gonzalez, B. Clotet, M. Artico, J.A. Este, G. Maga, and A. Mai, Journal of Medicinal Chemistry, 2012. 55(7): p. 3558-3562; ISI[000302591100058].

[WOS]. HIV_0608-062112.

37. Synthesis and anti-HIV Activity of Triazolo-fused 3',5'-cyclic Nucleoside Analogues Derived from an Intramolecular Huisgen 1,3-Dipolar Cycloaddition. Sun, J.B., X.Y. Liu, H.M. Li, R.H. Duan, and J.C. Wu, Helvetica Chimica Acta, 2012. 95(5): p. 772-779; ISI[000304084700008].

[WOS]. HIV_0608-062112.

38. A Novel High-throughput Screening Assay to Identify Inhibitors of HIV-1 gp120 Protein Interaction with DC-SIGN. Tran, T., R. El Baz, A. Cuconati, J. Arthos, P. Jain, and Z. Khan, Journal of Neurovirology, 2012. 18: p. 112-113; ISI[000304487800231].

[WOS]. HIV_0608-062112.

39. A Laccase with HIV-1 Reverse Transcriptase Inhibitory Activity from the Broth of Mycelial Culture of the Mushroom Lentinus tigrinus. Xu, L.J., H.X. Wang, and T. Ng, Journal of Biomedicine and Biotechnology, 2012. [Epub ahead of print]; ISI[000302682300001].

[WOS]. HIV_0608-062112.

Latent HIV Reactivation

40. Selected Drugs with Reported Secondarycell-differentiating Capacity Prime Latent HIV-1 Infection for Reactivation. Shishido, T., F. Wolschendorf, A. Duverger, F. Wagner, J. Kappes, J. Jones, and O. Kutsch, J Virol, 2012. [Epub ahead of print]; PMID[22696646].

[PubMed]. HIV_0608-062112.